HomeENTBF • OTCMKTS
add
Entheon Biomedical Corp
Previous close
$0.079
Year range
$0.050 - $0.11
Market cap
1.39M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
TBHC
0.00%
0.79%
Financials
Income Statement
Revenue
Net income
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 66.50K | -22.12% |
Net income | -65.01K | 22.43% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 321.84K | 135.79% |
Total assets | 353.78K | 91.09% |
Total liabilities | 29.75K | -25.26% |
Total equity | 324.03K | — |
Shares outstanding | 13.86M | — |
Price to book | 3.97 | — |
Return on assets | -43.68% | — |
Return on capital | -46.63% | — |
Cash Flow
Net change in cash
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Net income | -65.01K | 22.43% |
Cash from operations | -60.38K | 34.45% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -60.38K | 34.45% |
Free cash flow | -36.93K | 40.12% |
About
Founded
Jun 2019
Headquarters
Website
Employees
1